Scientists from the International Alzheimer’s Association, the University of Amsterdam and the American National Institute on Aging have presented new guidelines for diagnosing Alzheimer’s disease. International Alzheimer’s Congress (AAIC). It is now recommended to diagnose the disease using a blood test.
A study presented by Swedish scientists at the ADPD conference in March showed that blood biomarkers may be more reliable than a doctor’s examination. In addition, a blood test for the patient is much less inconvenient than the current diagnostic method, which requires a sample of cerebrospinal fluid. A blood test also costs less than a complex PET brain scan.
The authors of the new recommendations believe that soon both of these methods will be less in demand for diagnosing Alzheimer’s disease.
The scientists also said that a study conducted at the University of Amsterdam shows that many people with memory and thinking disorders want to know if they are in the early stages of Alzheimer’s disease. Diagnosis allows patients to better plan the next phase of their life.
Formerly doctors in your name The best hobbies for dementia prevention.